Paul Tudor Jones’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,100
Closed -$102K 3498
2024
Q3
$102K Sell
11,100
-56,700
-84% -$469K ﹤0.01% 2594
2024
Q2
$663K Buy
+67,800
New +$827K ﹤0.01% 1673
2024
Q1
Sell
-233,200
Closed -$5.03M 2775
2023
Q4
$5.03M Buy
+233,200
New +$4.3M 0.04% 634
2023
Q3
Sell
-18,600
Closed -$471K 2863
2023
Q2
$471K Buy
18,600
+5,400
+41% +$136K 0.01% 1741
2023
Q1
$342K Buy
+13,200
New +$353K 0.01% 1837
2022
Q3
Sell
-9,700
Closed -$322K 2699
2022
Q2
$322K Buy
9,700
+6,200
+177% +$263K 0.01% 1516
2022
Q1
$252K Buy
+3,500
New +$252K 0.01% 1647
2021
Q4
Sell
-14,200
Closed -$1.8M 2997
2021
Q3
$1.8M Buy
+14,200
New +$2.07M 0.03% 787

Other funds holding TDOC

Paul Tudor Jones's TDOC Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Teladoc Health (TDOC) in Q2 2026: 387,807 shares worth $3.29M. The stake represents ﹤0.01% of the portfolio and ranks #1583 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in TDOC as recently as Q3 2024.

Paul Tudor Jones first reported a position in TDOC in Q2 2018 and has held it in 15 quarters since. The position peaked at $5.33M in Q2 2023. 345 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Paul Tudor Jones held 387,807 shares of Teladoc Health worth $3.29M as of Q2 2026.
  • Teladoc Health was a new Paul Tudor Jones position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1583 holding.
  • Paul Tudor Jones first reported a position in Teladoc Health in Q2 2018 and has held it in 15 quarters since.
  • Paul Tudor Jones's Teladoc Health position peaked at $5.33M in Q2 2023.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.